Invesco’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-68,932
Closed -$43K 4177
2022
Q1
$43K Sell
68,932
-23,856
-26% -$18.4K ﹤0.01% 3944
2021
Q4
$103K Sell
92,788
-19,285
-17% -$29.8K ﹤0.01% 3899
2021
Q3
$208K Buy
112,073
+32,135
+40% +$72.2K ﹤0.01% 3786
2021
Q2
$253K Sell
79,938
-7,029,526
-99% -$17.6M ﹤0.01% 3702
2021
Q1
$23.1M Buy
7,109,464
+7,003,324
+6,598% +$25.4M 0.01% 1442
2020
Q4
$66K Sell
106,140
-4,575
-4% -$2.09K ﹤0.01% 3708
2020
Q3
$38K Sell
110,715
-3,656
-3% -$1.42K ﹤0.01% 3609
2020
Q2
$62K Sell
114,371
-14,683
-11% -$7.09K ﹤0.01% 3607
2020
Q1
$45K Buy
+129,054
New +$135K ﹤0.01% 3612
2019
Q4
Sell
-4,247
Closed -$34K 3718
2019
Q3
$34K Sell
4,247
-177
-4% -$2.41K ﹤0.01% 3659
2019
Q2
$78K Sell
4,424
-3,005
-40% -$65.8K ﹤0.01% 3694
2019
Q1
$230K Buy
7,429
+4,790
+182% +$161K ﹤0.01% 3591
2018
Q4
$78K Sell
2,639
-1,426
-35% -$64.8K ﹤0.01% 3672
2018
Q3
$306K Buy
4,065
+844
+26% +$57.1K ﹤0.01% 3605
2018
Q2
$183K Buy
+3,221
New +$117K ﹤0.01% 3715
2016
Q3
Sell
-27,712
Closed -$440K 3685
2016
Q2
$440K Buy
+27,712
New +$870K ﹤0.01% 3297
2015
Q3
Sell
-140
Closed -$5K 4026
2015
Q2
$5K Buy
+140
New +$6.45K ﹤0.01% 4226

Other funds holding ASXC

Invesco's ASXC Position: Q2 2022 in Review

Invesco sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 68,932 shares — an estimated $43K sold.

Invesco first reported a position in ASXC in Q2 2015 and held it in 17 quarters. The position peaked at $23.1M in Q1 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Invesco reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 68,932 Asensus Surgical, Inc. shares in Q2 2022, an estimated $43K.
  • Invesco first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 17 quarters.
  • Invesco's Asensus Surgical, Inc. position peaked at $23.1M in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.